Largest Unscheduled Purchases
The largest insider purchases not part of scheduled trading plans or 10% owner activity.
Director at American Bitcoin Corp. ($ABTC) purchased 101,000 shares at $1.98/share ($199.98K total), which increased their listed holdings by 11.22%. This is their 2nd largest purchase out of 2 all time. This insider has made 2 total purchases at this company in the last 30 days. Buying the dip (stock was down -56.46% in the month before the purchase). – SEC Source
General Partner at Global Partners LP ($GLP) purchased 4,330 shares at $42.84/share ($185.51K total), which increased their listed holdings by 1.92%. This is their 91st largest purchase out of 144 all time. This insider has made 7 total purchases at this company in the last 30 days. Appears to be regularly scheduled weekly transaction. – SEC Source
Director at Cooper Companies, Inc. ($COO) purchased 1,784 shares at $84.06/share ($149.96K total), which increased their listed holdings by 23.29%. This is their 1st largest purchase out of 3 all time. 5 insiders have made 5 total purchases at this company in the last 30 days. – SEC Source
Chief Executive Officer at WhiteHorse Finance, Inc. ($WHF) purchased 17,000 shares at $6.86/share ($116.60K total), which increased their listed holdings by 34.00%. This is their 1st largest purchase out of 8 all time. – SEC Source
Director at MAIA Biotechnology, Inc. ($MAIA) purchased 163,398 shares at $1.36/share ($111.11K total), which increased their listed holdings by 14.00%. 5 insiders have made 14 total purchases at this company in the last 30 days. Is part of a purchase agreement. – SEC Source
President and CEO at Protalix BioTherapeutics, Inc. ($PLX) purchased 56,000 shares at $1.81/share ($101.36K total), which increased their listed holdings by 2.26%. This is their 2nd largest purchase out of 3 all time. – SEC Source
Director at Amylyx Pharmaceuticals, Inc. ($AMLX) purchased 8,100 shares at $12.45/share ($100.84K total), which increased their listed holdings by 14.73%. This is their 2nd largest purchase out of 4 all time. – SEC Source
Largest Unscheduled Sales
The largest insider sales not part of scheduled trading plans or 10% owner activity.
Chairman and CEO at ConocoPhillips ($COP) sold 500,708 shares at $92.50/share ($46.32M total), which decreased their listed holdings by -52.08%. This is their 4th largest sale out of 8 all time. – SEC Source
Director at NVIDIA Corp. ($NVDA) sold 222,500 shares at $180.17/share ($40.09M total), which decreased their listed holdings by -0.65%. This is their 11th largest sale out of 54 all time. 7 insiders have made 9 total sales at this company in the last 30 days. – SEC Source
Director at GitLab Inc. ($GTLB) sold 334,827 shares at $38.08/share ($12.75M total), which decreased their listed holdings by -16.08%. This is their 8th largest sale out of 23 all time. 4 insiders have made 4 total sales at this company in the last 30 days. – SEC Source
Director at Olema Pharmaceuticals, Inc. ($OLMA) sold 264,800 shares at $29.73/share ($7.87M total), which decreased their listed holdings by -95.64%. This is their 1st largest sale out of 43 all time. 3 insiders have made 3 total sales at this company in the last 30 days. Selling the rip (stock was up 29.92% in the month before the sale). – SEC Source
Chief Medical Officer at Olema Pharmaceuticals, Inc. ($OLMA) sold 269,509 shares at $27.94/share ($7.53M total), which decreased their listed holdings by -49.63%. This is their 1st largest sale out of 1 all time. 3 insiders have made 3 total sales at this company in the last 30 days. Selling the rip (stock was up 29.92% in the month before the sale). – SEC Source
General Counsel at Arthur J. Gallagher & Co. ($AJG) sold 15,850 shares at $255.00/share ($4.04M total), which decreased their listed holdings by -8.43%. This is their 3rd largest sale out of 21 all time. 2 insiders have made 2 total sales at this company in the last 30 days. – SEC Source
Executive Chairman at Turning Point Brands, Inc. ($TPB) sold 30,000 shares at $110.26/share ($3.31M total), which decreased their listed holdings by -8.90%. This is their 1st largest sale out of 1 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 76.56% in the year before the sale). – SEC Source
Director at United Therapeutics Corp. ($UTHR) sold 5,950 shares at $512.13/share ($3.05M total), which decreased their listed holdings by -54.14%. This is their 4th largest sale out of 33 all time. 9 insiders have made 25 total sales at this company in the last 30 days. – SEC Source
Chief Executive Officer at Oracle Corp. ($ORCL) sold 10,000 shares at $192.52/share ($1.93M total), which decreased their listed holdings by -6.49%. This is their 4th largest sale out of 4 all time. 2 insiders have made 2 total sales at this company in the last 30 days. – SEC Source
President & CEO at Xencor Inc. ($XNCR) sold 114,377 shares at $15.71/share ($1.80M total), which decreased their listed holdings by -19.33%. This is their 2nd largest sale out of 5 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 48.94% in the three months before the sale). – SEC Source
CH. Discovery & Non-Clinical Dev. Officer at Olema Pharmaceuticals, Inc. ($OLMA) sold 51,000 shares at $30.46/share ($1.55M total), which decreased their listed holdings by -6.70%. This is their 1st largest sale out of 4 all time. 3 insiders have made 3 total sales at this company in the last 30 days. Is part of an Employee Stock Purchase Plan. Selling the rip (stock was up 29.92% in the month before the sale). – SEC Source
Co-President & CCO at Urban Outfitters, Inc. ($URBN) sold 18,666 shares at $80.76/share ($1.51M total), which decreased their listed holdings by -0.09%. This is their 6th largest sale out of 13 all time. 2 insiders have made 18 total sales at this company in the last 30 days. Appears to be regularly scheduled weekly transaction. Selling the rip (stock was up 29.71% in the month before the sale). – SEC Source
Director at Micron Technology, Inc. ($MU) sold 5,000 shares at $263.63/share ($1.32M total), which decreased their listed holdings by -20.71%. This is their 13th largest sale out of 21 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 35.51% in the month before the sale). – SEC Source
Director at Cytokinetics Inc. ($CYTK) sold 20,000 shares at $66.14/share ($1.32M total), which decreased their listed holdings by -38.14%. This is their 1st largest sale out of 2 all time. 6 insiders have made 8 total sales at this company in the last 30 days. Selling the rip (stock was up 32.01% in the three months before the sale). – SEC Source
Sr. Vice President – Comptroller at AMETEK, Inc. ($AME) sold 6,388 shares at $205.05/share ($1.31M total), which decreased their listed holdings by -18.13%. This is their 2nd largest sale out of 14 all time. 3 insiders have made 4 total sales at this company in the last 30 days. – SEC Source
President & CEO at Idaho Strategic Resources, Inc. ($IDR) sold 30,000 shares at $43.44/share ($1.30M total), which decreased their listed holdings by -4.31%. This is their 5th largest sale out of 7 all time. Selling the rip (stock was up 50.94% in the month before the sale). – SEC Source
President and COO at Kirby Corp. ($KEX) sold 11,145 shares at $111.68/share ($1.24M total), which decreased their listed holdings by -42.90%. This is their 4th largest sale out of 21 all time. 4 insiders have made 4 total sales at this company in the last 30 days. – SEC Source
Sr. Vice President & CSO at Xencor Inc. ($XNCR) sold 73,367 shares at $15.72/share ($1.15M total), which decreased their listed holdings by -22.81%. This is their 3rd largest sale out of 8 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 48.94% in the three months before the sale). – SEC Source
Director at CleanSpark, Inc. ($CLSK) sold 85,315 shares at $11.69/share ($997.11K total), which decreased their listed holdings by -42.31%. This is their 1st largest sale out of 3 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 27.57% in the month before the sale). – SEC Source
Largest Purchases by Percent Change
The insider sales that reduced ownership the most on a percentage basis.
Director at NIKE, Inc. ($NKE) purchased 50,000 shares at $58.97/share ($2.95M total), which increased their listed holdings by 90.12%. This is their 1st largest purchase out of 1 all time. 2 insiders have made 2 total purchases at this company in the last 30 days. Is part of a 10b5-1 plan. – SEC Source
N/A at Dorchester Minerals, L.P. ($DMLP) purchased 15,000 shares at $22.27/share ($334.12K total), which increased their listed holdings by 74.94%. This is their 9th largest purchase out of 56 all time. 5 insiders have made 7 total purchases at this company in the last 30 days. Is part of a 10b5-1 plan. Appears to be regularly scheduled yearly transaction. – SEC Source
Director at MAIA Biotechnology, Inc. ($MAIA) purchased 81,698 shares at $1.22/share ($50.00K total), which increased their listed holdings by 73.59%. This is their 2nd largest purchase out of 3 all time. 5 insiders have made 14 total purchases at this company in the last 30 days. Is part of a purchase agreement. – SEC Source
Director at MAIA Biotechnology, Inc. ($MAIA) purchased 81,698 shares at $1.36/share ($55.55K total), which increased their listed holdings by 73.59%. 5 insiders have made 14 total purchases at this company in the last 30 days. Is part of a purchase agreement. – SEC Source
PFO, PAO & Treasurer at Carlyle Credit Income Fund ($CCIF) purchased 1,200 shares at $4.70/share ($5.64K total), which increased their listed holdings by 48.00%. This is their 1st largest purchase out of 1 all time. – SEC Source
Chief Executive Officer at WhiteHorse Finance, Inc. ($WHF) purchased 17,000 shares at $6.86/share ($116.60K total), which increased their listed holdings by 34.00%. This is their 1st largest purchase out of 8 all time. – SEC Source
Director at NIKE, Inc. ($NKE) purchased 8,691 shares at $57.54/share ($500.08K total), which increased their listed holdings by 24.02%. This is their 6th largest purchase out of 17 all time. 2 insiders have made 2 total purchases at this company in the last 30 days. Is part of a 10b5-1 plan. – SEC Source
Director at Cooper Companies, Inc. ($COO) purchased 1,784 shares at $84.06/share ($149.96K total), which increased their listed holdings by 23.29%. This is their 1st largest purchase out of 3 all time. 5 insiders have made 5 total purchases at this company in the last 30 days. – SEC Source
Chief Financial Officer at Bimini Capital Management, Inc. ($BMNM) purchased 192,247 shares at $1.55/share ($297.98K total), which increased their listed holdings by 14.80%. 4 insiders have made 4 total purchases at this company in the last 30 days. Large price difference: Current: $2.04 | Tx: $1.55 | Diff: (+31.61%). – SEC Source
Director at Amylyx Pharmaceuticals, Inc. ($AMLX) purchased 8,100 shares at $12.45/share ($100.84K total), which increased their listed holdings by 14.73%. This is their 2nd largest purchase out of 4 all time. – SEC Source
Chief Executive Officer at Bimini Capital Management, Inc. ($BMNM) purchased 192,248 shares at $1.55/share ($297.98K total), which increased their listed holdings by 14.05%. 4 insiders have made 4 total purchases at this company in the last 30 days. Large price difference: Current: $2.04 | Tx: $1.55 | Diff: (+31.61%). – SEC Source
Director at MAIA Biotechnology, Inc. ($MAIA) purchased 163,398 shares at $1.22/share ($100.00K total), which increased their listed holdings by 14.00%. This is their 2nd largest purchase out of 3 all time. 5 insiders have made 14 total purchases at this company in the last 30 days. Is part of a purchase agreement. – SEC Source
Director at MAIA Biotechnology, Inc. ($MAIA) purchased 163,398 shares at $1.36/share ($111.11K total), which increased their listed holdings by 14.00%. 5 insiders have made 14 total purchases at this company in the last 30 days. Is part of a purchase agreement. – SEC Source
Director at American Bitcoin Corp. ($ABTC) purchased 101,000 shares at $1.98/share ($199.98K total), which increased their listed holdings by 11.22%. This is their 2nd largest purchase out of 2 all time. This insider has made 2 total purchases at this company in the last 30 days. Buying the dip (stock was down -56.46% in the month before the purchase). – SEC Source
Largest Sales by Percent Change
The insider sales that reduced ownership the most on a percentage basis.
Director at Alzamend Neuro, Inc. ($ALZN) sold 3,333 shares at $2.12/share ($7.06K total), which decreased their listed holdings by -100.00%. – SEC Source
Director at Novanta Inc. ($NOVT) sold 747 shares at $120.16/share ($89.76K total), which decreased their listed holdings by -100.00%. This is their 3rd largest sale out of 6 all time. This insider has made 2 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 20.86% in the month before the sale). – SEC Source
Director at FuelCell Energy Inc. ($FCEL) sold 8,608 shares at $8.52/share ($73.37K total), which decreased their listed holdings by -100.00%. This is their 1st largest sale out of 1 all time. Selling the rip (stock was up 31.84% in the month before the sale). – SEC Source
Director at Olema Pharmaceuticals, Inc. ($OLMA) sold 264,800 shares at $29.73/share ($7.87M total), which decreased their listed holdings by -95.64%. This is their 1st largest sale out of 43 all time. 3 insiders have made 3 total sales at this company in the last 30 days. Selling the rip (stock was up 29.92% in the month before the sale). – SEC Source
Chief Financial Officer at CRISPR Therapeutics AG ($CRSP) sold 10,000 shares at $55.95/share ($559.55K total), which decreased their listed holdings by -59.64%. This is their 1st largest sale out of 1 all time. Is part of a 10b5-1 plan. – SEC Source
Director at United Therapeutics Corp. ($UTHR) sold 5,950 shares at $512.13/share ($3.05M total), which decreased their listed holdings by -54.14%. This is their 4th largest sale out of 33 all time. 9 insiders have made 25 total sales at this company in the last 30 days. – SEC Source
Sr. Vice President and COO at Equillium, Inc. ($EQ) sold 100,000 shares at $1.50/share ($150.00K total), which decreased their listed holdings by -52.23%. This is their 1st largest sale out of 3 all time. This insider has made 3 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 31.73% in the month before the sale). – SEC Source
Chairman and CEO at ConocoPhillips ($COP) sold 500,708 shares at $92.50/share ($46.32M total), which decreased their listed holdings by -52.08%. This is their 4th largest sale out of 8 all time. – SEC Source
Chief Medical Officer at Olema Pharmaceuticals, Inc. ($OLMA) sold 269,509 shares at $27.94/share ($7.53M total), which decreased their listed holdings by -49.63%. This is their 1st largest sale out of 1 all time. 3 insiders have made 3 total sales at this company in the last 30 days. Selling the rip (stock was up 29.92% in the month before the sale). – SEC Source
President and COO at Kirby Corp. ($KEX) sold 11,145 shares at $111.68/share ($1.24M total), which decreased their listed holdings by -42.90%. This is their 4th largest sale out of 21 all time. 4 insiders have made 4 total sales at this company in the last 30 days. – SEC Source
Director at CleanSpark, Inc. ($CLSK) sold 85,315 shares at $11.69/share ($997.11K total), which decreased their listed holdings by -42.31%. This is their 1st largest sale out of 3 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 27.57% in the month before the sale). – SEC Source
Director at Cytokinetics Inc. ($CYTK) sold 20,000 shares at $66.14/share ($1.32M total), which decreased their listed holdings by -38.14%. This is their 1st largest sale out of 2 all time. 6 insiders have made 8 total sales at this company in the last 30 days. Selling the rip (stock was up 32.01% in the three months before the sale). – SEC Source
Director at QuantumScape Corp. ($QS) sold 157,171 shares at $11.38/share ($1.79M total), which decreased their listed holdings by -37.07%. This is their 18th largest sale out of 47 all time. 5 insiders have made 6 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 144.0% in the year before the sale). – SEC Source
Director at Mirum Pharmaceuticals, Inc. ($MIRM) sold 5,000 shares at $80.00/share ($400.00K total), which decreased their listed holdings by -33.33%. This is their 2nd largest sale out of 17 all time. 2 insiders have made 5 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 85.84% in the year before the sale). – SEC Source
Director at AnaptysBio, Inc. ($ANAB) sold 3,900 shares at $49.58/share ($193.34K total), which decreased their listed holdings by -28.82%. This is their 1st largest sale out of 1 all time. 4 insiders have made 6 total sales at this company in the last 30 days. Selling the rip (stock was up 49.03% in the month before the sale). – SEC Source
Director at Cipher Mining Inc. ($CIFR) sold 49,867 shares at $16.08/share ($801.86K total), which decreased their listed holdings by -23.97%. This is their 1st largest sale out of 2 all time. 4 insiders have made 4 total sales at this company in the last 30 days. Selling the rip (stock was up 191.59% in the year before the sale). – SEC Source
Director at Arrowhead Pharmaceuticals, Inc. ($ARWR) sold 10,000 shares at $67.66/share ($676.62K total), which decreased their listed holdings by -22.94%. This is their 1st largest sale out of 4 all time. 6 insiders have made 8 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 79.08% in the month before the sale). – SEC Source
Sr. Vice President & CSO at Xencor Inc. ($XNCR) sold 73,367 shares at $15.72/share ($1.15M total), which decreased their listed holdings by -22.81%. This is their 3rd largest sale out of 8 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 48.94% in the three months before the sale). – SEC Source
Chief Technology Officer at Robinhood Markets, Inc. ($HOOD) sold 5,864 shares at $122.39/share ($717.69K total), which decreased their listed holdings by -21.94%. This is their 5th largest sale out of 17 all time. 3 insiders have made 6 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 225.71% in the year before the sale). – SEC Source
Director at Arrowhead Pharmaceuticals, Inc. ($ARWR) sold 10,040 shares at $67.68/share ($679.49K total), which decreased their listed holdings by -21.94%. This is their 1st largest sale out of 3 all time. 6 insiders have made 8 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 79.08% in the month before the sale). – SEC Source
Director at Micron Technology, Inc. ($MU) sold 5,000 shares at $263.63/share ($1.32M total), which decreased their listed holdings by -20.71%. This is their 13th largest sale out of 21 all time. 2 insiders have made 2 total sales at this company in the last 30 days. Selling the rip (stock was up 35.51% in the month before the sale). – SEC Source
Director at Franklin Financial Services Corp. ($FRAF) sold 1,500 shares at $54.07/share ($81.11K total), which decreased their listed holdings by -20.43%. This is their 1st largest sale out of 1 all time. Selling the rip (stock was up 82.14% in the year before the sale). – SEC Source
Director at Rocket Lab Corp. ($RKLB) sold 27,314 shares at $68.21/share ($1.86M total), which decreased their listed holdings by -20.05%. This is their 1st largest sale out of 1 all time. 7 insiders have made 13 total sales at this company in the last 30 days. Is part of a 10b5-1 plan. Selling the rip (stock was up 83.13% in the month before the sale). – SEC Source
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
